HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…
Tianfu Rapoil Shines at Hong Kong Hometown Market Carnival
HONG KONG, June 2, 2025 /PRNewswire/ -- This is a report from Xinhuanet:…
LINKIN PARK ROCK THE UEFA CHAMPIONS LEAGUE FINAL KICK OFF SHOW PRESENTED BY PEPSI
MILLIONS OF FANS FROM ACROSS THE WORLD TUNED IN TO WATCH THE…
Celularity Receives Nasdaq Notice Regarding Form 10-Q
May 30, 2025 17:30 ET | Source: Celularity Inc. FLORHAM PARK, N.J.,…